Autopsy report · NCT02381795

Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache

“Terminated at the request of the financial sponsor.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Cady, Roger, M.D.

Sponsor type

University, hospital or other

Conditions

Cluster Headache

Interventions

Nasal Carbon Dioxide

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
  “Terminated due to the sponsor's decision.” (92% match in meaning)
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
  “Terminated by sponsor” (90% match in meaning)
• Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
  “Sponsor Terminated” (85% match in meaning)
• RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
  “Terminated by mutual agreement by sponsor and institution.” (83% match in meaning)
• A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
  “The sponsor voluntarily requested termination” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.